EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase II)Open Access

Clinical Pharmacology of Pemafibrate Extended-release Formulation in Patients with Hypertriglyceridemia—A Phase 2, Multicenter, Active-controlled, Randomized, Single-blind, Crossover study

Shizuya Yamashita, Eiichi Araki, Hidenori Arai, Koutaro Yokote, Ryohei Tanigawa, Ayumi Saito, Hideki Suganami, Sara Minamikawa, Shun Ishibashi

Journal of Atherosclerosis and Thrombosis · 2025

DOI: 10.5551/jat.65001 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2025. Verfasst von Shizuya Yamashita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Rinku General Medical Center. Hauptthemen laut MEDLINE: Hypertriglyceridemia, Butyrates, Benzoxazoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertriglyceridemiaButyratesBenzoxazolesHumansMaleFemaleMiddle AgedCross-Over StudiesDelayed-Action PreparationsSingle-Blind MethodTriglyceridesAgedAdult

Stichwörter der Autor:innen

Clinical pharmacologyExtended releasePemafibrateSelective PPARα modulatorTriglycerides

Substanzen

Delayed-Action Preparations(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acidButyratesBenzoxazolesTriglycerides

Autor:innen und Institutionen

  • Department of Cardiology, Rinku General Medical Center.
  • Kikuchi Medical Association Hospital.
  • Research Center for Health and Sports Sciences, Kumamoto Health Science University.
  • National Center for Geriatrics and Gerontology.
  • Chiba University.
  • Global Clinical Development Department, Kowa Company Ltd.

Zitieren

APA

Yamashita, S., Araki, E., Arai, H., Yokote, K., Tanigawa, R., Saito, A., Suganami, H., Minamikawa, S., & Ishibashi, S. (2025). Clinical Pharmacology of Pemafibrate Extended-release Formulation in Patients with Hypertriglyceridemia—A Phase 2, Multicenter, Active-controlled, Randomized, Single-blind, Crossover study. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.65001

Vancouver

Yamashita S, Araki E, Arai H, Yokote K, Tanigawa R, Saito A, et al. Clinical Pharmacology of Pemafibrate Extended-release Formulation in Patients with Hypertriglyceridemia—A Phase 2, Multicenter, Active-controlled, Randomized, Single-blind, Crossover study. Journal of Atherosclerosis and Thrombosis. 2025. doi:10.5551/jat.65001

BibTeX
@article{Yamashita2025,
  author = {Yamashita, Shizuya and Araki, Eiichi and Arai, Hidenori and Yokote, Koutaro and Tanigawa, Ryohei and Saito, Ayumi and Suganami, Hideki and Minamikawa, Sara and Ishibashi, Shun},
  title = {Clinical Pharmacology of Pemafibrate Extended-release Formulation in Patients with Hypertriglyceridemia—A Phase 2, Multicenter, Active-controlled, Randomized, Single-blind, Crossover study},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2025},
  doi = {10.5551/jat.65001}
}
Kostenlos starten →